400 patients have already tried it, and there is good news



[ad_1]

An HIV vaccine tested in 400 people has shown promising results by activating the immune system. However, the authors of the book have called for caution about their results

Research conducted by Dan Barouch, director of the Virology and Vaccines Research Center of Beth Israel Deaconess Medical Center, has shown that the experimental vaccine HIV-1 is tolerated According to the study published by the medical journal The Lancet, the volunteers of this research came from Thailand, the United States and South Africa. The tests performed also showed that it could work in humans from different parts of the planet since, in previous attempts, they had been restricted to specific geographical areas.

The next phase of the investigation will consist of conducting a prolonged clinical trial and vaccinating. 1,600 women in South Africa are at risk of contracting HIV.

AIDS was discovered only in the early 1980s, when American doctors observed that there was a group of patients with rare diseases and since that time has caused the death of more than 35 million people according to WHO figures.

However

[ad_2]
Source link